SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

BREAKING BOUNDARIES OF SCIENCE, TECHNOLOGY, MEDICINE, ART & HEALTHCARE POLICY

Session Chair: George Perry, PhD

3:30 – 3:45 PM
Is it Synapse Loss of Abnormality in Alzheimer’s Disease?

George Perry, PhD

Professor, Neuroscience, Developmental, and Regenerative Biology, UTSA College of Sciences; Editor in Chief of Journal of Alzheimer’s Disease, USA

3:45 – 4:00 PM
Alzheimer’s Disease and Chronic Traumatic Encephalopathy (CTE): Is their Etiology Related?

Jorge R Barrio, PhD

Emeritus Professor, Department of Molecular & Medical Pharmacology, David Geffen UCLA School of Medicine; Chair, Medical Radiation Safety & Radiation Drug Research Committee; Founding Editor-in-Chief, Molecular Imaging and Biology, CA, USA

4:00 – 4:15 PM
Can Calpain-2 Activation participate in Alzheimer’s Disease pathology?

Michel Baudry, PhD

Western University of Health Sciences, Pomona, CA, USA

4:15 – 4:30 PM
A gene-editing based therapeutic for Alzheimer’s Disease

Subhojit Roy, MD, PhD

Professor, Pathology, University of California, San Diego, CA, USA

4:30 – 5:00 PM
Q & A

Session Chair

March 16 @ 15:30
15:30 — 17:00 (1h 30′)

Room 409 B

Alzheimer’s Disease and Dementia

Add